Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
British Journal of Cancer, Published online: 20 May 2020; doi:10.1038/s41416-020-0867-xNeoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Changhoon Yoo Sang Soo Lee Ki Byung Song Jae Ho Jeong Jaewon Hyung Do Hyun Park Tae Jun Song Dong Wan Seo Sung Koo Lee Myung-Hwan Kim Seung Soo Lee Jin Hee Kim Hyung-seung Jin Jin-hong Park Dae Wook Hwang Jae Hoon Lee Woohyung Lee Heung-Moon Chang Kyu-pyo Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Study | UK Health